TABLE 1

Baseline characteristics

Diabetic subjectsNondiabetic subjects
n1275,118
Age (years)55.6 ± 5.755.3 ± 5.5
BMI (kg/m2)27.8 ± 3.725.9 ± 3.1
Alcohol (units/week)11 ± 1511 ± 13
Smoking (Y/N)58 (46)2,222 (43)
Pravastatin therapy52 (41)2,579 (50)
Systolic blood pressure (mmHg)138 ± 17135 ± 17
Diastolic blood pressure (mmHg)85 ± 1084 ± 10
Hypertension (Y/N)34 (27)793 (15)
Ln(triglyceride) [ln(mmol/l)]0.78 ± 0.390.51 ± 0.40
Total cholesterol (mmol/l)7.18 ± 0.617.02 ± 0.58
HDL cholesterol (mmol/l)1.04 ± 0.201.14 ± 0.24
Total cholesterol–to–HDL cholesterol ratio7.15 ± 1.486.41 ± 1.36
Glucose (mmol/l)5.48 ± 0.704.69 ± 0.49
Ln(WCC) [ln(109 cells/l)]1.94 ± 0.261.84 ± 0.27
Ln(sensitive CRP) [ln(mg/l)]1.05 ± 0.900.53 ± 1.08
  • Data for continuous measurements are means ± SD, and for categorical measurements, n (%). Baseline characteristics of subjects who had at least two post-randomization measurements of glucose, were not self-reported diabetic patients at baseline and did not have a fasting glucose at baseline ≥7.0 mmol/l, and had baseline plasma available for CRP measurements. Ln, natural logarithm.